Ryan Specialty (NYSE:RYAN) Posts Quarterly Earnings Results, Misses Estimates By $0.05 EPS

Ryan Specialty (NYSE:RYAN) released its quarterly earnings data on Thursday. The company reported $0.45 EPS for the quarter, missing the consensus estimate of $0.50 by ($0.05), FiscalAI reports. The business had revenue of $751.21 million during the quarter, compared to analysts’ expectations of $777.43 million. Ryan Specialty had a return on equity of 47.93% and a net margin of 7.61%.

Ryan Specialty Trading Up 3.1%

RYAN traded up $1.33 during trading on Thursday, hitting $44.38. The company’s stock had a trading volume of 3,379,001 shares, compared to its average volume of 1,673,352. Ryan Specialty has a twelve month low of $42.56 and a twelve month high of $77.16. The stock has a market cap of $11.71 billion, a PE ratio of 96.48, a PEG ratio of 1.13 and a beta of 0.62. The firm’s 50 day moving average price is $50.72 and its 200-day moving average price is $54.27. The company has a debt-to-equity ratio of 2.72, a current ratio of 1.00 and a quick ratio of 1.00.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on RYAN. Mizuho set a $60.00 price target on shares of Ryan Specialty in a report on Wednesday, January 14th. Cantor Fitzgerald reduced their target price on Ryan Specialty from $63.00 to $52.00 and set a “neutral” rating on the stock in a research note on Wednesday, January 14th. Weiss Ratings cut Ryan Specialty from a “hold (c-)” rating to a “sell (d+)” rating in a report on Thursday, February 5th. Keefe, Bruyette & Woods dropped their price target on Ryan Specialty from $73.00 to $65.00 and set an “outperform” rating for the company in a research report on Monday, November 3rd. Finally, Morgan Stanley set a $61.00 price objective on Ryan Specialty in a research report on Tuesday, December 16th. One equities research analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating, five have issued a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $64.19.

Insider Activity at Ryan Specialty

In other news, CEO Timothy William Turner sold 129,570 shares of Ryan Specialty stock in a transaction on Friday, December 12th. The stock was sold at an average price of $53.61, for a total value of $6,946,247.70. Following the completion of the sale, the chief executive officer owned 12,553 shares of the company’s stock, valued at $672,966.33. The trade was a 91.17% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 52.21% of the stock is currently owned by corporate insiders.

Institutional Trading of Ryan Specialty

A number of hedge funds have recently added to or reduced their stakes in RYAN. Royal Bank of Canada increased its stake in shares of Ryan Specialty by 10.6% during the 1st quarter. Royal Bank of Canada now owns 59,639 shares of the company’s stock valued at $4,406,000 after acquiring an additional 5,739 shares during the last quarter. AQR Capital Management LLC boosted its position in shares of Ryan Specialty by 25.1% in the first quarter. AQR Capital Management LLC now owns 4,972 shares of the company’s stock worth $367,000 after acquiring an additional 998 shares during the last quarter. Goldman Sachs Group Inc. grew its holdings in Ryan Specialty by 46.3% in the first quarter. Goldman Sachs Group Inc. now owns 376,154 shares of the company’s stock valued at $27,787,000 after purchasing an additional 119,055 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its position in Ryan Specialty by 11.3% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 332,823 shares of the company’s stock worth $24,586,000 after purchasing an additional 33,667 shares during the last quarter. Finally, Creative Planning raised its stake in Ryan Specialty by 15.4% during the second quarter. Creative Planning now owns 4,586 shares of the company’s stock worth $312,000 after purchasing an additional 613 shares during the period. 84.82% of the stock is owned by institutional investors and hedge funds.

About Ryan Specialty

Ryan Specialty Group, Inc (NYSE: RYAN) is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients’ unique needs.

Ryan Specialty’s core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.